COMPANY

Spirovant Sciences

HQ: Philadelphia, PA source · spirovant.com ↗ · Mid-Atlantic

Keywords: respiratory cystic fibrosis gene therapy AAV small molecule inhaled

Profile checked Oct 10, 2026

Timeline

Sep 16, 2024 Trial start 1: A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF) source ↗

Dec 31, 2026 (ESTIMATED) · 1 · A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF) · NCT06526923

Estimated primary completion per ClinicalTrials.gov. Dates move.

Record	Title	Phase	Status	Start	Primary completion
NCT06526923	A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)	1	Recruiting	Sep 16, 2024	Dec 31, 2026 (estimated)